A transcatheter mitral valve repair & replacement system is used to treat various mitral valve disorders (mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation) using minimally invasive transcatheter procedures. These less invasive procedures are suitable therapeutic alternatives for those people who cannot undergo open-heart surgery due to health concerns
The rising worldwide demand for transcatheter mitral valve repair & replacement systems is because of the increasing technological advancements in surgical procedures and upsurge in venture capital investments. For instance, the medical technology venture capital investment all over the world was valued at 5.7 billion U.S. dollars in 2019 which rose to 6.3 billion U.S. dollars in 2020. In addition to this, the largest increase in the MedTech venture capital investment was seen during the years 2016 and 2017
The growing prevalence of heart valve disease coupled with the rising geriatric population is another factor contributing to the growth of the global transcatheter mitral valve repair & replacement systems market. For instance, according to the United Nations, In 2019, 13.2% of the worldwide population was aged 60 years or above. Further, it is anticipated that nearly 21.4% of the total worldwide population will be aged 60 years or over by 2050. In view of these facts, there is an increase in the number of people who are not suitable for open-heart surgeries. As a result, there is an increase in the adoption of minimally invasive surgical procedures such as transcatheter mitral valve repair & replacement procedures augmenting the growth of transcatheter mitral valve repair & replacement market globally
Also Read: http://www.marketwatch.com/story/yacht-and-leisure-boat-market-rese...

For a better understanding of the market adoption of transcatheter mitral valve repair & replacement procedures, the market is
Some of the major players operating in the market include Medtronic PLC, Abbott Laboratories, Edwards Lifesciences Corporation, Colibri Heart Valve, LivaNova PLC, Boston Scientific Corporation, HighLife Medical, Neovasc Inc., Micro Interventional devices, JenaValve Technology. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
Also Read: http://www.marketwatch.com/story/varactor-diodes-market-research-re...

1.5 Currency Used in Report
1.6 Scope of the Global Transcatheter Mitral Valve Repair & Replacement Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Transcatheter Mitral Valve Repair & Replacement Market
2.1.1
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPS UNDER TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT SECTOR
6 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT COVID-19
7 GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET REVENUE (USD BN), 2021-2027F
8 MARKET INSIGHTS BY PRODUCT
8.1 Mechanical Valves
8.2 Bioprosthetic Tissue Valves
9 MARKET INSIGHTS BY INDICATION
9.1 Mitral Valve Stenosis
Also Read: http://www.marketwatch.com/story/transcatheter-mitral-valve-repair-...

9.2 Mitral Valve Prolapse
9.3 Mitral Valve Regurgitation
10 MARKET INSIGHTS BY REGION
10.1 North America Transcatheter Mitral Valve Repair & Replacement Market
10.1.1
10.1.2
10.1.3
10.2 Europe Transcatheter Mitral Valve Repair & Replacement Market
10.2.1
10.2.2
10.2.3
10.2.4
10.2.5
10.2.6
10.3 Asia Pacific Transcatheter Mitral Valve Repair & Replacement Market
10.3.1
10.3.2
10.3.3
10.3.4
10.3.5
10.4 Rest of World Transcatheter Mitral Valve Repair & Replacement Market
11 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET OPPORTUNITIES
13 TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET TRENDS
14 LEGAL & REGULATORY FRAMEWORK
15 DEMAND AND SUPPLY SIDE ANALYSIS
15.1 Demand Side Analysis
15.2 Supply Side Analysis
15.2.1
15.2.2
15.2.3
15.2.4
16 VALUE CHAIN ANALYSIS
17 COMPETITIVE SCENARIO
17.1 Porter’s Five Forces Analysis
17.1.1
17.1.2
17.1.3
17.1.4
17.1.5
17.2 Competitive Landscape
17.2.1
18 COMPANY PROFILED
18.1 Medtronic PLC
18.2 Abbott laboratories
18.3 Edwards Lifesciences Corporation
18.4 Colibri Heart Valve
18.5 LivaNova PLC
18.6 Boston Scientific Corporation
18.7 HighLife Medical
18.8 Neovasc Inc.
18.9 Micro Interventional devices
18.10 JenaValve Technology
19 DISCLAIMER ----

CONTACT DETAILS :

[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105